Skip to content

Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PGR 636, Ready-to-Use (Link)

by Dako North America, Inc.

510(k) K130861

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK130861 Date9 Dec 2013ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MXZ
Device Class
Class II
Regulation
21 CFR Part 864.1860
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an Immunohistochemistry Assay, Antibody, Progesterone Receptor, classified as a Class II medical device. It is a monoclonal mouse antibody (clone PGR 636) designed to detect human progesterone receptors in tissue samples. The antibody binds specifically to the progesterone receptor, enabling visualization and semi-quantitative assessment of receptor expression in formalin-fixed, paraffin-embedded specimens. Its primary application is within hematology and pathology diagnostics, supporting the evaluation of hormone receptor status in cancer tissue analysis.

The antibody is supplied as a ready-to-use reagent for immunohistochemistry, intended for use with automated staining systems such as the Autostainer Link. It is not sterile for surgical or invasive procedures but is packaged for laboratory use under controlled conditions. The device carries an FDA 510(k) clearance under the classification of Immunohistochemistry Assay, Antibody, Progesterone Receptor, with regulatory number 864.1860. No MRI safety or sterility for clinical use beyond laboratory diagnostics is indicated in the specifications.

Other devices from Dako North America, Inc.

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical use of this monoclonal antibody in pathology diagnostics?

    This antibody is designed specifically to detect human progesterone receptors in formalin-fixed, paraffin-embedded tissue samples. It enables pathologists to visualize and assess the presence and semi-quantitative levels of progesterone receptor expression, which is critical for evaluating hormone receptor status in cancer tissue—particularly in breast and other hormone-sensitive cancers—within hematology and pathology diagnostics.

  • How is this antibody supplied, and what systems is it compatible with for staining?

    The antibody is supplied as a ready-to-use reagent, eliminating the need for dilution or preparation by the user. It is intended for use exclusively with automated staining systems, such as the Autostainer Link, ensuring consistent and standardized immunohistochemical staining in laboratory settings.

  • Is this antibody sterile and suitable for direct patient use, or is it intended solely for laboratory diagnostics?

    This antibody is not sterile for surgical or invasive procedures and is not intended for direct patient use. It is packaged for laboratory diagnostics under controlled conditions, meaning it is designed for use in pathology labs to analyze tissue samples—never for clinical administration or patient contact.

  • What regulatory pathway was followed for this device’s clearance, and which advisory committee reviewed it?

    This device received FDA 510(k) clearance under the classification of an Immunohistochemistry Assay, Antibody, Progesterone Receptor (product code MXZ). The review was conducted by the Pathological Devices (PA) Panel of the Hematology Expert Panel (HE), with a decision of Substantially Equivalent (SESE) to a predicate device, as documented in the 510(k) submission.

  • Are there any specific storage or handling requirements mentioned for this antibody?

    While the provided data does not specify exact storage conditions, as a ready-to-use laboratory reagent, it should be stored according to standard protocols for immunohistochemistry antibodies—typically refrigerated (2–8°C) and protected from light. Always refer to the manufacturer’s instructions for precise handling, as improper storage could compromise its performance in detecting progesterone receptors.